Thiopurine methyltransferase predicts the extent of cytotoxicty and DNA damage in astroglial cells after thioguanine exposure.
Thiopurine methyltransferase (Tpmt) is the primary enzyme responsible for deactivating thiopurine drugs. Thiopurine drugs (i.e., thioguanine [TG], mercaptopurine, azathioprine) are commonly used for the treatment of cancer, organ transplant, and autoimmune disorders. Chronic thiopurine therapy has b...
Main Authors: | Amira Hosni-Ahmed, Joseph D Barnes, Jim Wan, Terreia S Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3244435?pdf=render |
Similar Items
-
Pharmacogenetic studies of thiopurines : focus on thiopurine methyltransferase
by: Lindqvist Appell, Malin
Published: (2005) -
Excited-State Dynamics of the Thiopurine Prodrug 6-Thioguanine: Can N9-Glycosylation Affect Its Phototoxic Activity?
by: Brennan Ashwood, et al.
Published: (2017-02-01) -
Establishment of human lymphoma cell lines with different thiopurine S-methyltransferase (TPMT) activities and differential proteome analysis after thiopurine exposure.
by: Misdaq, Misbah
Published: (2013) -
The role of thiopurine methyltransferase in the metabolism of cytotoxic drugs
by: Coulthard, Sally Anne
Published: (2000) -
Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population
by: Hamza Ben Zeglam, et al.
Published: (2015-03-01)